ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Grants For Action Plan On Breast Cancer

September 22, 1995

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012

BMS Award Honors Jordan; Matthews Media Wins $23 Million Contract From MCI.

April 6, 2001

In Brief: Minority Based CCOP Workshop Planned; NCI Changes To 800-4-CANCER On Levamisole

August 4, 1989

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982

New NCI Shakeup: O’Connor Leave DCCP to return To International Office; Adamson Acting Director

September 12, 1980